tiprankstipranks
Trending News
More News >
Larimar Therapeutics reports Q1 EPS (46c), consensus (41c)
PremiumThe FlyLarimar Therapeutics reports Q1 EPS (46c), consensus (41c)
20d ago
Larimar Therapeutics sees cash runway into 2Q26
Premium
The Fly
Larimar Therapeutics sees cash runway into 2Q26
20d ago
Larimar Therapeutics management to meet with Truist
Premium
The Fly
Larimar Therapeutics management to meet with Truist
21d ago
Larimar Therapeutics price target lowered to $10 from $13 at Baird
PremiumThe FlyLarimar Therapeutics price target lowered to $10 from $13 at Baird
2M ago
Larimar Therapeutics Reports 2024 Financial Results and Development Progress
Premium
Company Announcements
Larimar Therapeutics Reports 2024 Financial Results and Development Progress
2M ago
Promising Prospects for Larimar Therapeutics: Buy Rating Affirmed Amid FDA Support and Strong Financial Position
Premium
Ratings
Promising Prospects for Larimar Therapeutics: Buy Rating Affirmed Amid FDA Support and Strong Financial Position
2M ago
Apple downgraded, Rivian initiated: Wall Street’s top analyst calls
PremiumThe FlyApple downgraded, Rivian initiated: Wall Street’s top analyst calls
4M ago
Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
Premium
The Fly
Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
4M ago
Larimar Therapeutics initiated with a Buy at Truist
Premium
The Fly
Larimar Therapeutics initiated with a Buy at Truist
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100